BSE
Your Result on : Company News Details
Viyash Scientific Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
512529
ISIN Demat
INE807F01027
Book Value (Rs)
70.4015935
NSE Symbol
VIYASH
Divident Yield %
0
Market Cap
(Rs In Cr.)
11,581
P/E (TTM)
135.7
EPS (TTM)
1.94
Face Value
(Rs)
2
Back
Viyash Scientific to acquire Milan-based pet care company BioForLife
08-Jun-26   Hrs IST

Viyash Scientific (Viyash), through its wholly owned subsidiary Alivira Animal Health (Alivira), has signed a binding agreement to acquire 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy. The acquisition, for a cash consideration of Rs 188 crore is expected to close in Q2 FY27.

The transaction represents a significant step in Viyash's strategy to capitalize on the mega-trend of a growing Companion Animal Health Generics market. It expands Alivira's global Companion Animal Health business and strengthens its presence in the European pet care market.

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)